Cempra Initiates Solithromycin Pediatric Program

[GlobeNewswire] – CHAPEL HILL, N.C. — Cempra, Inc. today announced the dosing of the first patient in its Phase 1 study of solithromycin capsules in children. The clinical trial is funded through Cempra’s contract with … more

View todays social media effects on CEMP

View the latest stocks trending across Twitter. Click to view dashboard

See who Cempra is hiring next, click here to view